Your prescription drug benefit design places certain
If the drug you are searching for is not listed
drugs in certain categories to encourage the use of
below, you can search for it on the “Category
generics and provide low-cost options to you. The
1-4 Drug Search” page on www.bcbsms.com.
following information is applicable only to members
Remember, many drugs listed in category 4 have
with a 20% up to $100 copay for Category 4.
generic alternatives that are medically effective andcan save you money. High Blood Pressure Ace Inhibitor & Calcium Channel Blocker Combinations Category I Category 2 Category 3 Category 4 Ace Inhibitor-Nutritional Supplement Combinations Category I Category 2 Category 3 Category 4 Ace Inhibitors Category I Category 2 Category 3 Category 4 Ace Inhibitors & Thiazide / Thiazide-like Category I Category 2 Category 3 Category 4
Lisinop/HydrochlorothiazideQuinapril/HydrochlorothiazideQuinaretic
Blue Cross & Blue Shield of Mississippi, A Mutual Insurance Company, is an independent licensee of the Blue Cross and Blue Shield Association
®Registered Marks of the Blue Cross and Blue Shield Association, an Association of Independent Blue Cross and Blue Shield Plans. Adrenolytics-Central & Thiazide Combinations Category I Category 2 Category 3 Category 4 Adrenolytics-Peripheral & Thiazides Category I Category 2 Category 3 Category 4 Angiotensin II Receptor Antagonists Category I Category 2 Category 3 Category 4 Angiotensin II Receptor Antagonists & Thiazides Category I Category 2 Category 3 Category 4
AvalideBenicar HCTMicardis HCTTeveten HCT
Antiadrenergics - Centrally Acting Category I Category 2 Category 3 Category 4 Antiadrenergics - Peripherally Acting Category I Category 2 Category 3 Category 4 Antihypertensives-Misc. Category I Category 2 Category 3 Category 4 Beta Blocker & Diuretic Combinations Category I Category 2 Category 3 Category 4
Metroprolol/Hydrochlorothiazide Tenoretic 50Propranolol/Hydrochlorothiazide
Dopamine D1 Receptor Agonists Category I Category 2 Category 3 Category 4 Reserpine Category I Category 2 Category 3 Category 4 Reserpine Combinations Category I Category 2 Category 3 Category 4 Selective Aldosterone Receptor Antagonists (SRAS) Category I Category 2 Category 3 Category 4 Vasodilators Category I Category 2 Category 3 Category 4 Vasodilators & Thiazides Category I Category 2 Category 3 Category 4 Alpha-Beta Blockers Category I Category 2 Category 3 Category 4
CoregCoreg CRNormodyneTrandateTrandate IV
Beta Blockers Cardio-Selective Category I Category 2 Category 3 Category 4 Beta Blockers Non-Selective Category I Category 2 Category 3 Category 4
Innopran XLPropranololPropranolol HCL Intensol
Calcium Channel Blockers Category I Category 2 Category 3 Category 4
Nifedipine ERTaztia XTVerapamil HCLVerapamil HCL ERVerapamil HCL SR
Carbonic Anhydrase Inhibitors Category I Category 2 Category 3 Category 4 Diuretic Combinations Category I Category 2 Category 3 Category 4 Loop Diuretics Category I Category 2 Category 3 Category 4 Potassium Sparing Diuretics Category I Category 2 Category 3 Category 4 Thiazides and Thiazide-Like Diuretics Category I Category 2 Category 3 Category 4
Wolfe v McNeil-PPC, Inc. – A current application of the failure-to-warn doctrine. By Charles J. Crooks, Esquire, a member of Jackson Kelly PLLC For: Law360’s May 2011 Product Liability Guest Column N ew products are constantly being developed to meet modern needs and expectations. The law evolves to regulate the development, marketing and use of theseproducts. Tort law governs clai
Industry study benefi ts from Network know-howChildren with chronic kidney disease will benefi t from the results of an international clinical study led by a Manchester-based consultant working with the Medicines for Children Research Network (MCRN). This important commercial research study “I think the speed at which documents are step we could take to help other people. At looked at childr